Presentation TCT 2019 PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data Presenter: Sripal Bangalore September 27, 2019
Presentation TCT 2019 Double Indication for Impella CP: High-Risk Percutaneous Coronary Intervention (PCI) and Acute Myocardial Infarction Complicated by Cardiogenic Shock (AMICS) Presenter: Rafael Ferreira September 27, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
News TCT 2019 TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off Shelley Wood September 26, 2019
Presentation TCT 2019 TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI Presenter: Usman Baber September 26, 2019
News Conference News TCT 2019 AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups Todd Neale September 26, 2019
News Conference News TCT 2019 Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients L.A. McKeown September 26, 2019
Presentation TCT 2019 TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI Presenter: Roxana Mehran September 26, 2019
News Conference News TCT 2019 TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events Yael L. Maxwell September 26, 2019
Presentation TCT 2019 Case Resolution: How Did I Treat This Case? Presenter: Pengcheng He September 26, 2019
Presentation TCT 2019 Keynote Lecture 2: Intracoronary Imaging Guidance for High-Risk PCI Presenter: Junjie Zhang September 26, 2019
Presentation TCT 2019 Case Resolution: How Did I Treat This Case? Presenter: Lily Li September 26, 2019